Tdspharm Co., Ltd. (KOSDAQ:464280)

Tdspharm Revenue

Tdspharm had revenue of 8.07B KRW in the quarter ending March 31, 2026, with 52.87% growth. This brings the company's revenue in the last twelve months to 30.41B, up 19.57% year-over-year. In the year 2025, Tdspharm had annual revenue of 27.62B with 0.37% growth.

• Revenue (ttm): 30.41B
• Revenue Growth: +19.57%
• P/S Ratio: 1.18
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 35.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	27.62B	102.10M	0.37%
Dec 31, 2024	27.52B	-2.53B	-8.42%
Dec 31, 2023	30.05B	4.46B	17.43%
Dec 31, 2022	25.59B	5.77B	29.11%
Dec 31, 2021	19.82B	1.80B	9.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error